Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 644

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism

Open access
Duscha, Alexander, Gisevius, Barbara, Hirschberg, Sarah, Yissachar, Nissan, Stangl, Gabriele I., Dawin, Eva, Bader, Verian, Haase, Stefanie, Kaisler, Johannes, David, Christina, Schneider, Ruth, Troisi, Riccardo, Zent, Daniel, Hegelmaier, Tobias, Dokalis, Nikolaos, Gerstein, Sara, Del Mare-Roumani, Sara, Amidror, Sivan, Staszewski, Ori, Poschmann, Gereon, Stühler, Kai, Hirche, Frank, Balogh, Andras, Kempa, Stefan, Träger, Pascal, Zaiss, Mario M., Holm, Jacob Bak, Massa, Megan G., Nielsen, Henrik Bjørn, Faissner, Andreas, Lukas, Carsten, Gatermann, Sören G., Scholz, Markus, Przuntek, Horst, Prinz, Marco, Forslund, Sofia K., Winklhofer, Konstanze F., Müller, Dominik N., Linker, Ralf A., Gold, Ralf, Haghikia, Aiden·2020·Cell

Abstract

Short-chain fatty acids are processed from indigestible dietary fibers by gut bacteria and have immunomodulatory properties. Here, we investigate propionic acid (PA) in multiple sclerosis (MS), an autoimmune and neurodegenerative disease. Serum and feces of subjects with MS exhibited significantly reduced PA amounts compared with controls, particularly after the first relapse. In a proof-of-concept study, we supplemented PA to therapy-naive MS patients and as an add-on to MS immunotherapy. After 2 weeks of PA intake, we observed a significant and sustained increase of functionally competent regulatory T (Treg) cells, whereas Th1 and Th17 cells decreased significantly. Post-hoc analyses revealed a reduced annual relapse rate, disability stabilization, and reduced brain atrophy after 3 years of PA intake. Functional microbiome analysis revealed increased expression of Treg-cell-inducing genes in the intestine after PA intake. Furthermore, PA normalized Treg cell mitochondrial function and morphology in MS. Our findings suggest that PA can serve as a potent immunomodulatory supplement to MS drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.02.035

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

See all 644

Metadata

Authors
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., Bader, V., Haase, S., Kaisler, J., David, C., Schneider, R., Troisi, R., Zent, D., Hegelmaier, T., Dokalis, N., Gerstein, S., Del Mare-Roumani, S., Amidror, S., Staszewski, O., Poschmann, G., Stühler, K., Hirche, F., Balogh, A., Kempa, S., Träger, P., Zaiss, M. M., Holm, J. B., Massa, M. G., Nielsen, H. B., Faissner, A., Lukas, C., Gatermann, S. G., Scholz, M., Przuntek, H., Prinz, M., Forslund, S. K., Winklhofer, K. F., Müller, D. N., Linker, R. A., Gold, R., & Haghikia, A.
Venue
Cell
Publisher
Elsevier BV
Published
2020-03
Volume
180
Issue
6
Pages
1067-1080.e16
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3010923525
Cited by
644
References
57
FWCI
49.83
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism. https://app.cochat.ai/papers/10.1016/j.cell.2020.02.035
The paper
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., Bader, V., Haase, S., Kaisler, J., David, C., Schneider, R., Troisi, R., Zent, D., Hegelmaier, T., Dokalis, N., Gerstein, S., Del Mare-Roumani, S., Amidror, S., Staszewski, O., . . . Haghikia, A. (2020). Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism. Cell. https://doi.org/10.1016/j.cell.2020.02.035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.